Barry P.
- Country
- Ireland
- Department
- Adult CF Centre
Research Overview
- Phase 2 Randomized Double‑Blind Study of VX-828/Deutivacaftor With and Without Tezacaftor in Adults with Cystic Fibrosis
- Evaluation of Long-term Safety and Efficacy of Tezacaftor, Deutivacaftor, and Vanzacaftor Combination Therapy in Patients with Cystic Fibrosis
- Efficacy and Safety of BI 1291583 in Patients with Bronchiectasis: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 54 of 203 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in the treatment and research of cystic fibrosis, focusing on innovative therapeutic approaches for managing this genetic condition.
- Genetic respiratory disorders
- Advanced therapeutic combinations
- Long-term disease management
Their work centers on evaluating novel treatment options for patients with cystic fibrosis, particularly exploring combination therapies that target the underlying cause of the disease.
Therapeutic Innovation
The investigator's expertise extends to studying advanced combination therapies for genetic disorders, with particular attention to safety and tolerability profiles in clinical applications.
- Novel therapeutic compounds
- Drug safety assessment
- Treatment optimization
Their research encompasses the evaluation of innovative pharmaceutical combinations designed to address complex genetic conditions.
Clinical Development
The investigator focuses on long-term therapeutic outcomes in genetic respiratory conditions, evaluating the sustained effectiveness of treatment protocols.
- Treatment efficacy assessment
- Patient monitoring protocols
- Clinical outcome evaluation
Their clinical research emphasizes the importance of comprehensive patient assessment in the context of chronic genetic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.